Robust equity market conditions and sustained investor demand for growth-oriented names have kept the 2026 IPO window open, with 246 U.S. offerings priced year-to-date as of mid-September and additional deals reaching final prospectus stage in recent days. Smaller and mid-sized issuers, including recent biotech and insurance debuts, continue to price successfully, while larger candidates such as Anthropic have adjusted timelines into November amid regulatory and valuation considerations. OpenAI has signaled a 2027 target, yet the broader pipeline of active S-1 filings and confidential registrations supports further listings before year-end. Key near-term catalysts include macroeconomic data releases and any shifts in Treasury yields that could influence underwriting calendars.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · UpdatedDiscord IPO probability collapses amid regulatory delays and market uncertainty
Discord plunges to 11%18%
Discord's expected IPO timeline shifted from early 2026 to mid-2027 due to SEC backlog and valuation concerns, causing market probabilities for a 2026 IPO to collapse and delaying its public debut.

































Beware of external links.
Beware of external links.
Frequently Asked Questions